Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 09, 2020

SELL
$54.34 - $94.85 $20.1 Million - $35.1 Million
-369,676 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$29.67 - $80.0 $649,624 - $1.75 Million
-21,895 Reduced 5.59%
369,676 $23.7 Million
Q1 2020

May 12, 2020

BUY
$17.78 - $31.58 $6.96 Million - $12.4 Million
391,571 New
391,571 $11.7 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Key Square Capital Management LLC Portfolio

Follow Key Square Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Key Square Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Key Square Capital Management LLC with notifications on news.